H-DTLVNRIEL-OH

Ref. 3D-PP44829

Informação sobre produto

• Nome: H-DTLVNRIEL-OH
• Sinónimos: NH2-Asp-Thr-Leu-Val-Asn-Arg-Ile-Glu-Leu-OH

Descrição

Peptide H-DTLVNRIEL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DTLVNRIEL-OH include the following: Improved cytotoxic T-lymphocyte immune responses to a tumor antigen by vaccines co-expressing the SLAM-associated adaptor EAT-2 YA Aldhamen , SS Seregin , YA Kousa - Cancer gene , 2013 - nature.comhttps://www.nature.com/articles/cgt201353 Deimmunisation of Enhanced Green Fluorescent Protein TJ Eyes - 2014 - search.proquest.comhttps://search.proquest.com/openview/7699ac614c7856c453899cebf8df06c3/1?pq-origsite=gscholar&cbl=2026366&diss=y Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of MA Brimble , CL Morton, SM Winston - Human Gene , 2024 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/hum.2023.188 Transgenic mouse model expressing P53R172H, luciferase, EGFP and KRASG12D in a single open reading frame for live imaging of tumor HL Ju, DF Calvisi, H Moon, S Baek, S Ribback - Scientific reports, 2015 - nature.comhttps://www.nature.com/articles/srep08053 Defining Factors that Determine Effective Anti-Melanoma Tumor Immunity D Thakral - 2019 - search.proquest.comhttps://search.proquest.com/openview/1d492759a5970032f643772751892f2b/1?pq-origsite=gscholar&cbl=18750&diss=y The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ A Arina, O Murillo, S Hervas-Stubbs - journal of cancer, 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.22795

• Marca: Biosynth